Literature DB >> 21348780

Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.

Nele Berghmans1, Amber Nuyts, Catherine Uyttenhove, Jacques Van Snick, Ghislain Opdenakker, Hubertine Heremans.   

Abstract

Th17 cells are suggested to be pathogenic in mediating experimental autoimmune encephalomyelitis (EAE), but their relation to interferon (IFN)-γ-producing Th1 cells in vivo is not well understood. We studied the numbers and functions of Th17 cells in CREAE in Biozzi ABH mice, both in peripheral lymphoid organs and in the central nervous system. Th1 and Th17 cells alternated in secondary lymphoid organs and infiltrated into the central nervous system during chronic relapsing experimental autoimmune encephalomyelitis (CREAE). In the absence of IFN-γ the numbers and secretion of Th17 cells was enhanced, whereas exogenous administration of IFN-γ decreased the Th17 cells. In mice with intact IFN-γ genes, in vivo neutralization of interleukin (IL)-17 protected against EAE development by enhancing the number of IFN-γ-producing cells. IFN-γ knockout mice were partially protected by anti-IL-17 antibodies by decreasing cell numbers and production of IL-17. Our findings suggest that, whereas IFN-γ as such is not necessary for EAE development in the mouse, the lack of suppression of Th17 cells by IFN-γ enhances the susceptibility to develop EAE. IFN-γ thus orchestrates the number and function of Th17 cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21348780     DOI: 10.1089/jir.2010.0137

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  12 in total

1.  Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis.

Authors:  Yan-Hua Li; Jie-Zhong Yu; Chun-Yun Liu; Hui Zhang; Hai-Fei Zhang; Wan-Fang Yang; Jun-Lian Li; Qian-Jin Feng; Ling Feng; Guang-Xian Zhang; Bao-Guo Xiao; Cun-Gen Ma
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

2.  Absence of IFN-γ increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the central nervous system.

Authors:  Ashutosh K Mangalam; Ningling Luo; David Luckey; Louisa Papke; Alyssa Hubbard; Arika Wussow; Michele Smart; Shailendra Giri; Moses Rodriguez; Chella David
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

3.  Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; SuFey Ong; DeLisa Fairweather; Djahida Bedja; Natalie R Stickel; Jillian A Fontes; Ashley B Cardamone; Dongfeng Zheng; Kathleen L Gabrielson; Noel R Rose; Daniela Ciháková
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

4.  Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways.

Authors:  Zhizheng Zhao; Huiting Fan; Tim Higgins; Jia Qi; Diana Haines; Anna Trivett; Joost J Oppenheim; Hou Wei; Jie Li; Hongsheng Lin; O M Zack Howard
Journal:  Cancer Lett       Date:  2014-09-19       Impact factor: 8.679

5.  Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.

Authors:  N Marín; H Eixarch; M J Mansilla; E Rodríguez-Martín; M Mecha; C Guaza; J C Álvarez-Cermeño; X Montalban; L M Villar; C Espejo
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

6.  Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.

Authors:  Eun Young Choi; Jong-Hyung Lim; Ales Neuwirth; Matina Economopoulou; Antonios Chatzigeorgiou; Kyoung-Jin Chung; Stefan Bittner; Seung-Hwan Lee; Harald Langer; Maryna Samus; Hyesoon Kim; Geum-Sil Cho; Tjalf Ziemssen; Khalil Bdeir; Emmanouil Chavakis; Jae-Young Koh; Louis Boon; Kavita Hosur; Stefan R Bornstein; Sven G Meuth; George Hajishengallis; Triantafyllos Chavakis
Journal:  Mol Psychiatry       Date:  2014-11-11       Impact factor: 15.992

Review 7.  Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Authors:  Gabriel Arellano; Payton A Ottum; Lilian I Reyes; Paula I Burgos; Rodrigo Naves
Journal:  Front Immunol       Date:  2015-09-29       Impact factor: 7.561

8.  Targeting innate receptors with MIS416 reshapes Th responses and suppresses CNS disease in a mouse model of multiple sclerosis.

Authors:  Madeleine White; Gill Webster; David O'Sullivan; Sarrabeth Stone; Anne Camille La Flamme
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.

Authors:  Nichole M Miller; Jun Wang; Yanping Tan; Bonnie N Dittel
Journal:  Front Neurosci       Date:  2015-08-18       Impact factor: 4.677

10.  Chemokine receptor expression by inflammatory T cells in EAE.

Authors:  Jyothi Thyagabhavan Mony; Reza Khorooshi; Trevor Owens
Journal:  Front Cell Neurosci       Date:  2014-07-04       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.